Furthermore, levels of Rap1 are positively regulated by NF‐κB, and human breast cancers with NF‐κB hyperactivity show elevated levels of cytoplasmic Rap1 (Teo et al., 2010). The gene discussed is NFKB1; the disease is breast carcinoma.